Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Electronic Resource
    Electronic Resource
    Springer
    Intensive care medicine 22 (1996), S. 1406-1409 
    ISSN: 1432-1238
    Keywords: Keywords Respiratory failure ; Mitochondrial myopathy ; Acid maltase deficiency ; Intermittent positive pressure ventilation ; Carnitine palmitoyl transferase deficiency
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract   Objective: To describe how patients cope with the propos-al of treatment with intermittent artificial ventilation after acute respiratory failure due to progressive respiratory muscle weakness. Design: Case series, follow-up study. Setting: Neurological intensive care unit (ICU). Patients: 7 consecutive patients with metabolic myopathy treated for acute respiratory failure between 1983 and 1992. interventions: Intermittent positive pressure ventilation (IPPV) via tracheostomy. Measurements and results: Symptoms of chronic hypoventilation preceded acute respiratory failure for months. With one exception, patients were mainly disabled from respiratory muscle weakness and sleep-related breathing disorders. IPPV was recommended to prevent recurrent respiratory failure. Two of 28.8nthree patients who accepted home IPPV returned to full-time jobs. One patient, who decided against IPPV, died from CO2 narcosis several months after discharge. All patients adhered to the respiratory regimen once instituted. Conclusions: Acute respiratory failure in chronic myopathy is heralded by daytime drowsiness. IPPV, or at least regular monitoring of waking and sleeping partial pressure of carbon dioxide, is highly recommended even if weaning is successful. IPPV improved quality of life. The treatment strategy at discharge from the ICU should be optimal, as patients are reluctant to modify regimens.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    Electronic Resource
    Electronic Resource
    Springer
    Intensive care medicine 22 (1996), S. 1406-1409 
    ISSN: 1432-1238
    Keywords: Respiratory failure ; Mitochondrial myopathy ; Acid maltase deficiency ; Intermittent positive pressure ventilation ; Carnitine palmitoyl transferase deficiency
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract Objective To describe how patients cope with the proposal of treatment with intermittent artificial ventilation after acute respiratory failure due to progressive respiratory muscle weakness. Design Case series, follow-up study. Setting Neurological intensive care unit (ICU). Patients 7 consecutive patients with metabolic myopathy treated for acute respiratory failure between 1983 and 1992. Interventions Intermittent positive pressure ventilation (IPPV) via tracheostomy. Measurements and results Symptoms of chronic hypoventilation preceded acute respiratory failure for months. With one exception, patients were mainly disabled from respiratory muscle weakness and sleep-related breathing disorders. IPPV was recommended to prevent recurrent respiratory failure. Two of three patients who accepted home IPPV returned to full-time jobs. One patient, who decided against IPPV, died from CO2 narcosis several months after discharge. All patients adhered to the respiratory regimen once instituted. Conclusions Acute respiratory failure in chronic myopathy is heralded by daytime drowsiness. IPPV, or at least regular monitoring of waking and sleeping partial pressure of carbon dioxide, is highly recommended even if weaning is successful. IPPV improved quality of life. The treatment strategy at discharge from the ICU should be optimal, as patients are reluctant to modify regimens.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...